SciELO - Scientific Electronic Library Online

 
vol.139 número4Vitiligo y terapia con inmunoglobulina intravenosa: a propósito de un paciente con síndrome de SjögrenExperiencia internacional en relación al reposo médico y a la protección de los trabajadores frente a la incapacidad transitoria de generar ingresos: referente para el caso chileno índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

VEGA, Jorge; GOECKE, Helmuth  e  SANTAMARINA, Mario. Retroperitoneal fibrosis associated with chronic use of ergotamine: Report of one case. Rev. méd. Chile [online]. 2011, vol.139, n.4, pp.489-494. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872011000400012.

Retroperitoneal fibrosis (RPF) associated with chronic use of ergotamine is a very rare disorder. We report a 45-year-old woman who presented with a RPf after using, almost daily for 23 years, ergotamine tartrate for migraine relief. FRP presented as a chronicinflammatory state, anemia, abdominal and lumbosacral pain and a hypogastric mass. A CT-Scan showed a periaortic mass and left hydronephrosis. A percutaneous biopsy was obtained and the patient was subjected to a surgical ureterolysis and tissue resection. The biopsy confirmed the presence of RPf. Due to persistent symptoms and increase in the volume of periaortic tissue, treatment with colchicine 1 mg/day and defazacort 30 mg/day was started, resulting in a rapid di-sappearance of symptoms, disappearance ofinflammation and a significant reduction in the volume of the periaortic tissue. The patient remains in complete remission after 29 months of follow up.

Palavras-chave : Anti inflammatory agents; Colchicine; Ergotamine; Retroperitoneal fibrosis.

        · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons